Pico-Tesla Magnetic Therapies, LLC
News Releases

Magneceutical Health Announcement October 10, 2011

Pico-Tesla reports promising results in Fibromyalgia study, April 13 2011

Pico-Tesla receives ISO 13485:2003 certification, March 14, 2011

Pico-Tesla starts Alzheimer’s disease Study with University of South Florida (USF) Health Byrd Alzheimer’s Institute, Jan 5, 2011

Pico-Tesla expands Pivotal clinical trial for Parkinson’s disease, Jan 4, 2011

Pico-Tesla begins Pilot Study in Fibromyalgia, Dec 15, 2010

Pico-Tesla elects Jack Calderon to its Board, September 29, 2010

Pico-Tesla expands operations to the Midwest, August 26, 2010

Pico-Tesla's Magneceutical® Therapy featured in EP Lab Digest,
August 10, 2010

Electromagnetic fields can suppress atrial fibrillation, May 24, 2010

Dr. Bellido elected as Director of Pico-Tesla, May 10, 2010

Pico-Tesla Opens East Coast Headquarters, March 15, 2010

Phase III clinical trial of Magneceutical® therapy for Parkinson's Disease, October 5, 2009

Pilot Study, Parkinson's Disease, September 18, 2009


 

 

Please Download the latest version of Adobe Flash Player.

 

ABOUT US

Our Team

Participate in our research
News Releases

Terms & Conditions of Use

Click Here for FDA Approval Status
 
 
 
   

 

 
 

4700 140th Ave. N., Suite 101 • Clearwater, FL 33762 • 727-474-3722

HOME | CONTACT US

 
 

The Resonator™ device is an Investigational Device limited by Federal (or United States)
law to investigational use. The Resonator™ device is not for sale, nor is the Magneceutical®
Therapy generally available outside of Investigational Review Board (IRB) approved clinical studies.